文献速递淋巴瘤

总代谢肿瘤体积、循环肿瘤细胞与游离DNA在滤泡性淋巴瘤中的不同预后价值

Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
PubMed 文献 · Blood Adv · 2018-01-01

该回顾性研究纳入133例初治滤泡性淋巴瘤患者,分析基线总代谢肿瘤体积(TMTV)与循环肿瘤细胞(CTCs)、游离DNA(cfDNA)的相关性及预后价值。TMTV与CTCs、cfDNA均显著相关;中位随访48个月,TMTV>510 cm³、CTCs>0.0018 PB细胞或cfDNA>2550 equivalent-genome/mL者4年PFS更低;多因素分析中cfDNA与TMTV均保持预后预测价值。

要点

  • TMTV与CTCs(P<.0001)及cfDNA(P<.0001)均显著相关
  • TMTV>510 cm³者4年PFS更低(P=.0004)
  • 多因素分析中cfDNA与TMTV均保持预后预测价值

核心结论

  • CTCs和cfDNA与滤泡性淋巴瘤的TMTV相关,三者均影响患者结局。
  • 高cfDNA和高TMTV患者PFS更短,提示这些参数为肿瘤定制治疗提供相关信息。

研究设计与样本

  • 回顾性分析133例既往未治疗且具有基线PET的滤泡性淋巴瘤患者,来自2个队列,分别有基线血浆样本(n=61)或bcl2-JH可提供信息的外周血样本(n=68)。
  • 通过微滴数字聚合酶链反应定量循环bcl2-JH+细胞和cfDNA。

主要发现

  • TMTV与CTCs显著相关(P<.0001),与cfDNA也显著相关(P<.0001)。
  • 中位随访48个月,TMTV>510 cm³患者4年PFS更低(P=.0004)。
  • CTCs>0.0018 PB细胞患者4年PFS更低(P=.03)。
  • cfDNA>2550 equivalent-genome/mL患者4年PFS更低(P=.04)。
  • 与单独TMTV相比,检测CTCs未获得额外预后信息;Cox多因素分析包括cfDNA和TMTV显示两者均保持对结局的预测价值。

关键数值与推荐

  • TMTV阈值510 cm³,CTCs阈值0.0018 PB细胞,cfDNA阈值2550 equivalent-genome/mL。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Outcomes for follicular lymphoma (FL) have greatly improved, but most patients will ultimately relapse. High total metabolic tumor volume (TMTV), computed from baseline 18F-fluorodeoxyglucose-positron emission tomography (PET), is associated with shorter progression-free survival (PFS), but circulating tumor cells (CTCs) and cell-free DNA (cfDNA) may also reflect tumor burden and be of prognostic value. The aim of our study was to correlate CTCs and cfDNA with TMTV in FL at diagnosis and to determine their prognostic values. We retrospectively analyzed 133 patients (with previously untreated FL and a baseline PET) from 2 cohorts with either a baseline plasma sample (n = 61) or a bcl2-JH-informative peripheral blood (PB) sample (n = 68). Quantification of circulating bcl2-JH+ cells and cfDNA was performed by droplet digital polymerase chain reaction. A significant correlation was found between TMTV and both CTCs (P < .0001) and cfDNA (P < .0001). With a median 48-month follow-up, 4-year PFS was lower in patients with TMTV > 510 cm3 (P = .0004), CTCs >0.0018 PB cells (P = .03), or cfDNA >2550 equivalent-genome/mL (P = .04). In comparison with TMTV alone, no additional prognostic information was obtained by measuring CTCs. In contrast, Cox multivariate analysis, including cfDNA and TMTV, showed that both cfDNA and TMTV remained predictive of outcome. In conclusion, CTCs and cfDNA correlate with TMTV in FL, and all 3 influence patient outcome. PFS was shorter for patients with high cfDNA and TMTV, suggesting that these parameters provide relevant information for tumor-tailored therapy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Delfau-Larue MH, van der Gucht A, Dupuis J, et al. Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma. Blood Adv. 2018. PMID: 29636326. doi:10.1182/bloodadvances.2017015164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。